Delivery Order SPE2DR25D3016-SPE2DR26FG2GN
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,274.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Quviviq 50 mg on November 25, 2025, with an ultimate completion date of November 26, 2025. The award is unclassified with no set-aside designation and represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,712.87 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quviviq 25 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $1,233.40 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of QUVIVIQ 50MG tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of December 16, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a $1,877.08 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Quivivq 50 mg tablets (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,081.69 Firm Fixed Price Delivery Order is for the supply of 4566178485 QUVIVIQ 50 MG TABLET 30S, with a period of performance through October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $1,188.39 to AmerisourceBergen Drug Corp for Quuviq 50 mg tablets (30-count packaging), with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,692.28 Delivery Order contract is for the supply of the medication QUVIVIQ 50 MG TABLET 30S, with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,575.24 firm fixed-price delivery order is for the supply of QUVIVIQ 25 MG TABLET 30S, a medication, to support military healthcare programs. The contract has an ultimate completion date of February 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $739 to Amerisourcebergen Drug Corporation. The order is for 4562315414, Quviviq 25mg tablets, to be delivered within a single day in September 2023 to a location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will perform as the prime contractor, with parent company Amerisourcebergen Corporation. The delivery order was issued under an existing DLA contract vehicle to supply...